Compound brief
DSIP
Evidence brief. Not treatment advice or a safety clearance. Last evidence update: September 2026.
What researchers are studying it for
Delta-sleep-inducing peptide. The sequence is small and polar. A receptor comparable to GHSR or GLP-1R has not been established in this seed.
Forum certainty about a single receptor is ahead of the chemistry stored here.
Pathway
Sleep circuitry involves GABA, adenosine, orexin, and monoamines. DSIP was named for a delta-sleep effect in early animal work. A single receptor that explains forum sleep reports was not extracted.
If sedation is real it would sit beside benzodiazepines and opioids as an additive concern. That concern stays inferred and thin.
Forum themes
Forum themes are unverified. They do not outrank a study, and they are not a dose.
No forum theme is stored for this compound.